Helus Pharma Inc. (HELP)
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
Helus Pharma Inc. Common Stock
NASDAQ:HELPHealthcare · Medical - Pharmaceuticals
AHAfter hours+0.64%$9.43
Prev close$8.96+4.58%Close$9.37+0.64%Now$9.43
Close$9.37+4.58%
Mkt Cap$684.66M
Float50.07M
O/S73.07M
VOL1.6M sh
$ Vol$14.93M
RVOL1.04×
Inst Own42.5%
Dilution